ASCO 2019 | Future treatment options for squamous cell lung cancer
Paul Paik
Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.
Related videos
2:31 RESILIENT: liposomal irinotecan in relapsed SCLC
David R. Spigel
7:34 Intracranial activity of selpercatinib in RET fusion positive NSCLC
Vivek Subbiah
8:06 ADAURA: osimertinib post-tumor resection in NSCLC
Roy Herbst
3:32 Cancer care in the time of COVID-19
Melissa Johnson
4:29 FIH study of CX-2029 in patients with advanced cancer
Melissa Johnson
